Fig. 1
From: Predictors of continuation for asenapine from real-world data in patients with schizophrenia
Kaplan–Meier survival analysis of time to asenapine discontinuation for any reason. Analysis of patients treated with either more than 600 mg/day or less of antipsychotics (chlorpromazine-equivalent doses), and with a duration of more than 25 years or less at the initiation of treatment with asenapine. CP: Chlorpromazine